Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
4-[2-(2-Benzyloxycarbonylamino-3-t-butoxy-butyrylamino)-4-methyl-pentanoylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
Tetrandrine
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021
Peginterferon alfa-2b
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/10/2021
Ginkgolic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/28/2021
Azanitrile 8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
Pyridyl ester 17
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
Interferon alfa-2b
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/30/2020
ΔABP-α2
Potential treatment - theoretical effect Experimental Antiviral Mar/01/2021
Hypothiocyanite
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/19/2021
Suramin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/05/2021
Quercetagetin 7-glucoside
Potential treatment - theoretical effect Natural product Antiviral Feb/15/2021
Anacardic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Echinacoside
Potential treatment - theoretical effect Natural product Antiviral Feb/15/2021
Cleistanthin B
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/25/2021
Diphyllin
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/25/2021
Berberine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/22/2021
GRL0617
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/20/2021
J08-MUT
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/23/2021
aly-miR396a-5p
Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021
VS12
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021